Patents by Inventor Ju-Mi Kim

Ju-Mi Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240154131
    Abstract: Provided is a catalyst layer for fuel cell having improved heat-dissipating performance and durability. The catalyst layer for fuel cell according to the present invention is a catalyst layer for fuel cell comprising a first composite and a second composite, wherein the first composite includes: a supporting material, a catalyst including metal particles supported on the supporting material, and a first ionomer coated on the surface of the catalyst; the second composite includes a heat-dissipating material and a second ionomer, the second ionomer is not coated on the surface of the catalyst, and the first ionomer and the second ionomer are identical with or different from each other.
    Type: Application
    Filed: February 15, 2022
    Publication date: May 9, 2024
    Inventors: Jung Ho KIM, Jun Young KIM, Kah Young SONG, Nak Won KONG, Ju Sung LEE, Kyoung Sik NAM, Chan Mi PARK
  • Publication number: 20240110990
    Abstract: Discussed is an electrode tab disconnection inspection apparatus of a battery cell that can include an impedance measurement part connected to electrode leads of a battery cell to be inspected, and configured to measure an impedance value according to a frequency of the battery cell; and a determination part configured to compare impedance value data according to the frequency of the battery cell to be inspected acquired by the impedance measurement part and a predetermined impedance value data group according to a frequency of normal battery cells having no disconnected electrode tabs or a frequency of tab disconnected battery cells having disconnected electrode tabs to determine whether the electrode leads of the battery cell to be inspected is disconnected.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 4, 2024
    Applicant: LG ENERGY SOLUTION, LTD.
    Inventors: Ju Mi LEE, Ju Young KIM, In Hwan CHO
  • Publication number: 20240100629
    Abstract: The present disclosure discloses a substrate heat-treating apparatus including a process chamber in which a flat substrate to be heat treated is placed, the process chamber comprising a beam transmitting plate placed below the flat substrate and an infrared transmitting plate placed above the flat substrate; a beam irradiating module for irradiating a VCSEL beam having a single wavelength to a lower surface of the flat substrate through the beam transmitting plate; and an temperature measuring module configured to measure the laser beam reflected from the lower surface or an upper surface the flat substrate, thereby measuring the temperature of the flat substrate.
    Type: Application
    Filed: December 29, 2021
    Publication date: March 28, 2024
    Inventors: Hyoung June Kim, Byung Kuk Kim, Wang Jun Park, Tae Hyeong Kim, Ju Mi Lee, Byeong Gyu Jeong
  • Publication number: 20230343994
    Abstract: The present disclosure relates to an all-solid-state secondary battery, and more particularly, to an all-solid-state secondary battery including a positive electrode, a negative electrode, and a solid electrolyte layer disposed between the positive electrode and the negative electrode. Here, at least one of the positive electrode and the negative electrode includes a sulfide-based active material, the sulfide-based active material has a particle size of about 50 nm to about 5 µm, and the sulfide-based active material has a grain size of about 1 nm to about 10 nm.
    Type: Application
    Filed: April 26, 2022
    Publication date: October 26, 2023
    Inventors: Ju Young KIM, Young-Gi LEE, Yong Min LEE, Seok Hun KANG, Kwang Man KIM, Ju Mi KIM, Joonam PARK, Dong Ok SHIN, Jimin OH, Myeong Ju LEE
  • Patent number: 10418188
    Abstract: In a method for manufacturing a supercapacitor, a first graphene current collector, a first electrode and a first separating layer are sequentially formed on a first metal layer, to form a first stacked layer. A second graphene current collector and a second electrode are sequentially formed on a second metal layer, to form a second stacked layer. The second electrode of the second stacked layer is formed on the first separating layer of the first stacked layer, to form a third stacked layer. The third stacked layer is compressed to remove the first and second metal layers, to form a unit stacked layer. The unit stacked layer and a second separating layer or an insulating layer are alternately formed.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: September 17, 2019
    Assignee: KOREA INSTITUTE OF MACHINERY & MATERIALS
    Inventors: Jae-hyun Kim, Seung-mo Lee, Bong-kyun Jang, In-kyu You, Sung-hoon Hong, Ju-mi Kim, Bit-na Kim
  • Publication number: 20190066935
    Abstract: In a method for manufacturing a supercapacitor, a first graphene current collector, a first electrode and a first separating layer are sequentially formed on a first metal layer, to form a first stacked layer. A second graphene current collector and a second electrode are sequentially formed on a second metal layer, to form a second stacked layer. The second electrode of the second stacked layer is formed on the first separating layer of the first stacked layer, to form a third stacked layer. The third stacked layer is compressed to remove the first and second metal layers, to form a unit stacked layer. The unit stacked layer and a second separating layer or an insulating layer are alternately formed.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 28, 2019
    Inventors: Jae-hyun KIM, Seung-mo LEE, Bong-kyun JANG, In-kyu YOU, Sung-hoon HONG, Ju-mi KIM, Bit-na KIM
  • Patent number: 9809583
    Abstract: Provided are novel selective androgen receptor agonists, a preparation method thereof, and a pharmaceutical composition including the same at a pharmaceutically effective amount. The selective androgen receptor agonists according to the present invention act on androgen receptors to increase androgen activity, thereby being usefully applied as a therapeutic and prophylactic agent for diseases or conditions, of which symptoms may be improved or may respond to treatment by increased activities of androgen receptors, namely, a variety of hormone-related diseases in male and female, muscle wasting disorders, osteoporosis, etc.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: November 7, 2017
    Assignee: DONG-A ST CO., LTD.
    Inventors: Sung Pil Choi, Seul Min Choi, Byoung Hwa Son, Hyun Jung Kim, Ju Mi Kim, Byung Jun Jang, Ji Hyun Sung, Ji Hye Lee, Eunjin Kim, Kyung Koo Kang, Soon-Hoe Kim
  • Publication number: 20170050955
    Abstract: Provided are novel selective androgen receptor agonists, a preparation method thereof, and a pharmaceutical composition including the same at a pharmaceutically effective amount. The selective androgen receptor agonists according to the present invention act on androgen receptors to increase androgen activity, thereby being usefully applied as a therapeutic and prophylactic agent for diseases or conditions, of which symptoms may be improved or may respond to treatment by increased activities of androgen receptors, namely, a variety of hormone-related diseases in male and female, muscle wasting disorders, osteoporosis, etc.
    Type: Application
    Filed: April 7, 2015
    Publication date: February 23, 2017
    Applicant: DONG-A ST CO., LTD.
    Inventors: Sung Pil Choi, Seul Min Choi, Byoung Hwa Son, Hyun Jung Kim, Ju Mi Kim, Byung Jun Jang, Ji Hyun Sung, Ji Hye Lee, Eunjin Kim, Kyung Koo Kang, Soon-Hoe Kim
  • Publication number: 20150213964
    Abstract: Provided are an electrolyte for a dye-sensitized solar cell and a dye-sensitized solar cell including the same. The electrolyte for a dye-sensitized solar cell includes an organic solvent, a metal anion compound, and a quaternary ammonium salt compound (R4N+X?). X? and Y? are multi-redox systems which are in chemical equilibrium.
    Type: Application
    Filed: July 25, 2014
    Publication date: July 30, 2015
    Applicant: Electronics and Telecommunications Research Institute
    Inventors: Jeumjong KIM, Moo Jung CHU, Ju Mi KIM
  • Patent number: 8928158
    Abstract: An epoxy resin composition for encapsulating a semiconductor device includes a curing agent, a curing accelerator, inorganic fillers, and an epoxy resin, the epoxy resin including a first resin represented by Formula 1: wherein R1 and R2 are each independently hydrogen or a C1 to C4 linear or branched alkyl group, and n is a value from 1 to 9 on average.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: January 6, 2015
    Assignee: Cheil Industries Inc.
    Inventors: Seung Han, Ju Mi Kim, Sung Su Park, Eun Jung Lee
  • Publication number: 20130158165
    Abstract: An epoxy resin composition for encapsulating a semiconductor device and a semiconductor device encapsulated with the composition, the composition including an epoxy resin; an inorganic filler; a curing accelerator; and a curing agent, the curing agent including a compound having a multifunctional novolac structure including at least one biphenyl moiety, the compound being represented by Formula 1: wherein n is about 1 to about 10.
    Type: Application
    Filed: December 19, 2012
    Publication date: June 20, 2013
    Inventors: Seung HAN, Ju Mi KIM, Sung Su PARK, Eun Jung LEE
  • Publication number: 20120302667
    Abstract: An epoxy resin composition for encapsulating a semiconductor device includes a curing agent, a curing accelerator, inorganic fillers, and an epoxy resin, the epoxy resin including a first resin represented by Formula 1: wherein R1 and R2 are each independently hydrogen or a C1 to C4 linear or branched alkyl group, and n is a value from 1 to 9 on average.
    Type: Application
    Filed: May 23, 2012
    Publication date: November 29, 2012
    Applicant: CHEIL INDUSTRIES, INC.
    Inventors: Seung HAN, Ju Mi KIM, Sung Su PARK, Eun Jung LEE
  • Publication number: 20120288983
    Abstract: Disclosed is a method for manufacturing a dye sensitized solar cell module. The method includes putting at least one or more heating-wires on an upper portion of an electrode of each solar cell sub-module; applying a metal paste on the upper portion of the electrode including at least one or more heating-wires; and heating and curing the metal paste by after overlapping the electrodes of a plurality of solar cell sub-modules each other, allowing a current to flow to at least one or more heating-wires.
    Type: Application
    Filed: April 30, 2012
    Publication date: November 15, 2012
    Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Moo Jung Chu, Ju Mi Kim, Yong Sung Eom, Ah Ram Jeon, Jong Tae Moon
  • Publication number: 20120266959
    Abstract: A semiconductor electrode for a dye-sensitized solar cell, a method of manufacturing the semiconductor electrode, and a dye-sensitized solar cell having the semiconductor electrode are provided which can prevent electrons from being transported to an electrolyte from the surface of the semiconductor electrode to raise photocurrent and photovoltage and to improve an energy conversion efficiency by forming a semiconductor oxide layer on a conductive substrate, forming an organic layer in a core-shell structure thereon, and adsorbing a dye on the organic layer through the use of an electrostatic attraction.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 25, 2012
    Applicant: Sungkyunkwan University Foundation for Corporate Collaboration
    Inventors: Byungyou Hong, Hyung Jin Kim, Minjae Shin, Ju Mi Kim
  • Patent number: 8203011
    Abstract: The present invention provides a 3?,4?,5-trimethoxy flavone derivative and a pharmaceutically acceptable salt thereof, preparation thereof, and a pharmaceutical composition for the treatment and prevention of dry eye syndrome comprising the same as an active ingredient. The 3?,4?,5-trimethoxy flavone derivative and its pharmaceutically acceptable salt inhibit corneal damage through excellent stimulatory action on mucus secretion in the conjunctiva and therefore may be effective as a prophylactic or therapeutic agent for dry eye syndrome.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: June 19, 2012
    Assignee: Dong-A Pharm. Co., Ltd.
    Inventors: Seul-Min Choi, Kyung-Koo Kang, Dong-Sung Kim, Jeong-Hoon Kim, Byoung-Ok Ahn, Moo-Hi Yoo, Mi-Jeong Seo, Ju-Mi Kim, Yong-Duck Kim, Sun-Woo Jang, Yong-Sung Shon
  • Patent number: 7919318
    Abstract: The present invention provides a process for isolating vascular endothelial cells from embryoid bodies differentiated from embryonic stem cells, which comprises: (a) treating embryoid bodies differentiated from embryonic stem cells with 0.005-0.015% trypsin and 0.05-0.15 mM ethylenediaminetetraacetate (EDTA) to obtain vascular endothelial cell clusters; and (b) treating the vascular endothelial cell clusters with 0.1-0.5% trypsin and 0.5-2 mM EDTA so as to separate the vascular endothelial cell clusters into single cells.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: April 5, 2011
    Assignees: Chabio & Diostech Co., Ltd., College of Medicine Pochon Cha University Industry-Academic Cooperation Foundation
    Inventors: Hyung-Min Chung, Sung-Hwan Moon, Ju-Mi Kim, Soo-Hong Lee
  • Publication number: 20100221833
    Abstract: The present invention provides a process for differentiation of vascular endothelial progenitor cells from embryoid bodies derived from embryonic stem cells, the process comprising: (a) treating a culture medium comprising embryoid bodies derived from embryonic stem cells such that the concentration of oxygen dissolved in the culture medium is in the range of about 1 ppm to about 5 ppm; (b) culturing the culture medium prepared in step (a) in an incubator in which the oxygen (O2) tension is equal to or less than about 15% to differentiate the embryoid bodies into vascular endothelial progenitor cells; and (c) isolating the vascular endothelial progenitor cells from the culture medium obtained in step (b).
    Type: Application
    Filed: August 14, 2008
    Publication date: September 2, 2010
    Applicants: CHABIO & DIOSTECH CO., LTD., COLLEGE OF MEDICINE POCHON CHA UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION,
    Inventors: Hyung-Min Chung, Ju-Mi Kim, Soo-Hong Lee, Sung-Hwan Moon
  • Publication number: 20100210668
    Abstract: The present invention relates to a composition and a method for treating or preventing benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) without showing the side effect, by dramatically relaxing the smooth muscle in prostate and bladder.
    Type: Application
    Filed: September 24, 2008
    Publication date: August 19, 2010
    Applicant: DONG-A PHARM. CO., LTD.
    Inventors: Seul-Min Choi, Ju-Mi Kim, Kyung-Koo Kang, Byoung-Ok Ahn, Moo-Hi Yoo
  • Publication number: 20100144032
    Abstract: The present invention provides a process for isolating vascular endothelial cells from embryoid bodies differentiated from embryonic stem cells, which comprises: (a) treating embryoid bodies differentiated from embryonic stem cells with 0.005-0.015% trypsin and 0.05-0.15 mM ethylenediaminetetraacetate (EDTA) to obtain vascular endothelial cell clusters; and (b) treating the vascular endothelial cell clusters with 0.1-0.5% trypsin and 0.5-2 mM EDTA so as to separate the vascular endothelial cell clusters into single cells.
    Type: Application
    Filed: June 13, 2007
    Publication date: June 10, 2010
    Applicant: CHABIOTECH CO., LTD.
    Inventors: Hyung-Min Chung, Sung-Hwan Moon, Ju-Mi Kim, Soo-Hong Lee
  • Publication number: 20100130448
    Abstract: The present invention provides a 3?,4?,5-trimethoxy flavone derivative and a pharmaceutically acceptable salt thereof, preparation thereof, and a pharmaceutical composition for the treatment and prevention of dry eye syndrome comprising the same as an active ingredient. The 3?,4?,5-trimethoxy flavone derivative and its pharmaceutically acceptable salt inhibit corneal damage through excellent stimulatory action on mucus secretion in the conjunctiva and therefore may be effective as a prophylactic or therapeutic agent for dry eye syndrome.
    Type: Application
    Filed: June 2, 2008
    Publication date: May 27, 2010
    Applicant: DONG-A PHARM. CO., LTD
    Inventors: Seul-Min Choi, Kyung-Koo Kang, Dong-Sung Kim, Jeong-Hoon Kim, Byoung-Ok Ahn, Moo-Hi Yoo, Mi-Jeong Seo, Ju-Mi Kim, Yong-Duck Kim, Sun-Woo Jang, Yong-Sung Shon